Evidence map›Paper›PMID 29861622›Full record

ArticleInfectious diseases in obstetrics and gynecology2018

Acceptability and Feasibility of Integrating Point-of-Care Diagnostic Testing of Sexually Transmitted Infections into a South African Antenatal Care Program for HIV-Infected Pregnant Women.

E Morikawa, M Mudau, D Olivier, L de Vos, D Joseph Davey, C Price, J A McIntyre, R P Peters, J D Klausner, A Medina-Marino

Open access · hybridAbstract read
In one paragraph

Article in Infectious diseases in obstetrics and gynecology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 4 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 4 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Prevalence ofInternational journal of women's health · 2026
    Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

E MorikawaDivision of Infectious Disease, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.ORCID 0000-0001-8582-9018
M MudauResearch Unit, Foundation for Professional Development, Pretoria, South Africa.
D OlivierResearch Unit, Foundation for Professional Development, Pretoria, South Africa.
L de VosResearch Unit, Foundation for Professional Development, Pretoria, South Africa.
D Joseph DaveyDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA.
C PriceDivision of Infectious Disease, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
J A McIntyreAnova Health Institute, Johannesburg, South Africa.
R P PetersAnova Health Institute, Johannesburg, South Africa.
J D KlausnerDivision of Infectious Disease, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.ORCID 0000-0002-6922-7364
A Medina-MarinoResearch Unit, Foundation for Professional Development, Pretoria, South Africa.
Foundation for Professional Development · ZAUniversity of California, Los Angeles · USUniversity of Cape Town · ZAMaastricht University · NL

Funding

Postdoctoral Training in Global AIDS Prevention ResearchT32MH080634 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JESSE LAWTON CLARK, Pamina Mae Gorbach · 2007 to 2026
$6.4M
Pilot Study of STI Screening and Treatment for PMTCTR21HD084274 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KLAUSNER, JEFFREY DAVID, MEDINA-MARINO, ANDREW · 2015 to 2016
$352k
NICHD NIH HHS R21 HD084274NIMH NIH HHS T32 MH080634
6 · The paper itself

Abstract

Background: Objective: To describe the acceptability and feasibility of integrating diagnostic STI screening into first antenatal care visits for HIV-infected pregnant women. Methods: HIV-infected pregnant women were recruited during their first antenatal care visit from three antenatal care clinics in Tshwane District, South Africa, between June 2016 and October 2017. Self-collected vaginal swabs were used to screen for CT, NG, and TV with a diagnostic point-of-care (POC) nucleic acid amplification test. Those with STIs were provided treatment per South African national guidelines. Results: Of 442 eligible women, 430 (97.3%) agreed to participate and were tested. Of those with a positive STI test result ( Conclusions: Integration of POC diagnostic STI screening into first-visit antenatal care services was feasible and highly acceptable for HIV-infected pregnant women.

Indexed as

Point-of-Care TestingAdultAsymptomatic InfectionsChlamydia InfectionsFeasibility StudiesFemaleGonorrheaHIV InfectionsHumansPatient Acceptance of Health CarePregnancyPregnancy Complications, InfectiousPrenatal CareSouth AfricaTrichomonas Infections

Identifiers

PMID29861622
PMCPMC5971359
OpenAlexW2800475778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.